Our Team
Samit Shah MD, PhD
Koen Vanderschuren PhD
Koen Vanderschuren PhD
Founder
Dr. Shah is an Interventional Cardiologist and physician-scientist at Yale, nationally recognized for advancing coronary physiology and women’s heart disease. He leads the DISCOVER INOCA registry, and was awarded the 2025 Blavatnik Fund for Innovation award to support Angiomedix. His research work is supported by grants from Women’
Founder
Dr. Shah is an Interventional Cardiologist and physician-scientist at Yale, nationally recognized for advancing coronary physiology and women’s heart disease. He leads the DISCOVER INOCA registry, and was awarded the 2025 Blavatnik Fund for Innovation award to support Angiomedix. His research work is supported by grants from Women’s Health Research at Yale and the FDA Office of Women's Health.
Koen Vanderschuren PhD
Koen Vanderschuren PhD
Koen Vanderschuren PhD
Head of Operations
Dr. Vanderschuren earned his PhD in Molecular Biology from Yale, where he developed bioengineering strategies to optimize biologics. As a former Project Leader at BCG and current Blavatnik Fellow with Yale Ventures, he brings deep expertise in R&D strategy, manufacturing optimization, and commercial execution to drive Angiomedix’s operational growth.
Carolyn M. Mazure PhD
Koen Vanderschuren PhD
Carolyn M. Mazure PhD
Advisor
Dr. Mazure is a leading expert in women’s health research and policy, serving as the inaugural Chair of the White House Initiative on Women’s Health Research. She founded Women’s Health Research at Yale, a nationally recognized center advancing interdisciplinary science and innovation, and brings decades of leadership experience in NIH-funded research and women's health innovation.
Alexandra Lansky MD
Koen Vanderschuren PhD
Carolyn M. Mazure PhD
Advisor
Dr. Lansky is Professor of Medicine at Yale and a global leader in cardiovascular clinical research. She has directed numerous trials in interventional cardiology, and shaped international practice guidelines. Her expertise in device evaluation and regulatory strategy brings unparalleled insight to Angiomedix’s innovation and clinical development.
